Geode Capital Management
UTRS

Geode Capital Management’s Minerva Surgical, Inc. Common Stock UTRS Stock Holding History

Geode Capital Management’s Portfolio UTRS Stock Details UTRS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-10,379
Closed -$34.5K – 4802
2023
Q3 		$34.5K Buy
10,379
+3,942
+61% +$18K ﹤0.01% 4519
2023
Q2 		$33K Buy
6,437
+4,764
+285% +$23.3K ﹤0.01% 4586
2023
Q1 		$7.34K Sell
1,673
-23
-1% -$142 ﹤0.01% 4779
2022
Q4 		$7K Hold
1,696
– – ﹤0.01% 4869
2022
Q3 		$26K Hold
1,696
– – ﹤0.01% 4879
2022
Q2 		$79K Hold
1,696
– – ﹤0.01% 4668
2022
Q1 		$152K Buy
+1,696
New +$172K ﹤0.01% 4501

Geode Capital Management's UTRS Position: Q4 2023 in Review

Geode Capital Management sold out of Minerva Surgical, Inc. Common Stock (UTRS) in Q4 2023, closing a stake of 10,379 shares — an estimated $34.5K sold.

Geode Capital Management first reported a position in UTRS in Q1 2022 and held it in 7 quarters. The position peaked at $152K in Q1 2022. 0 funds tracked by Wall St. Rank hold UTRS as of Q4 2023.

  • Geode Capital Management reported no remaining Minerva Surgical, Inc. Common Stock position as of Q4 2023 after selling out during the quarter.
  • Geode Capital Management sold 10,379 Minerva Surgical, Inc. Common Stock shares in Q4 2023, an estimated $34.5K.
  • Geode Capital Management first reported a position in Minerva Surgical, Inc. Common Stock in Q1 2022 and held it in 7 quarters.
  • Geode Capital Management's Minerva Surgical, Inc. Common Stock position peaked at $152K in Q1 2022.
  • 0 funds tracked by Wall St. Rank held Minerva Surgical, Inc. Common Stock as of Q4 2023.

Based on Geode Capital Management's 13F filing for Q4 2023, filed 13 Feb 2024.